The pace with which the Lifesciences Industry is evolving and transforming is impressive. The industry moves towards personalized medicine, collaborative innovation, technology-centric drug research and device development, and leveraging enterprise-wide business data. It is also being challenged by escalating drug discovery costs, a stricter regulatory environment, and the time-bound imperative of modernizing and integrating siloed legacy systems.